| Announce Date | 10/06/2025 |
| EPS Normalized Actual | $-0.09 (Beat by $0.03) |
| EPS GAAP Actual | $-0.09 (Beat by $0.03) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.01 |
| EPS GAAP Estimate | $0.01 |
| Revenue Estimate | $0.0008B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0.51 | 9.84 | 0.51 | 0.51 | 0 |
| Dec 2027 | 0.73833 | 6.8 | 0.73833 | 0.73833 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2021 (Jun 2021) | -0.3089 | -0.3089 | 0B | NAN% | 0M |
| FQ2 2025 (Jun 2025) | 0.0342 | 0.1142 | 0.000325451B | 97.46% | -0.1M |
| FQ3 2024 (Sep 2024) | -0.23 | -0.16 | 4.5436E-5B | -1124.3% | -0.29M |
| FQ4 2024 (Dec 2024) | -0.23 | -0.16 | 4.5436E-5B | -812.95% | -0.31M |
| FQ2 2024 (Jun 2024) | -0.0862 | -0.0162 | 8.261E-6B | 100% | -0.31M |
| FQ3 2021 (Sep 2021) | -0.0011 | -0.0011 | 0B | NAN% | 0M |
| FQ4 2021 (Dec 2021) | -0.0111 | -0.0111 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | -0.05 | -0.05 | 4.1389E-5B | 100% | 0.04M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.01
Consensus Revenue Estimates
0.0008B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | -0.16 | -- | -0.16 | -0.16 | 1 |
| FQ2 2027 (Jun 2027) | -0.16 | -- | -0.16 | -0.16 | 1 |
| FQ1 2027 (Mar 2027) | -0.16 | -- | -0.16 | -0.16 | 1 |
| FQ4 2026 (Dec 2026) | 0.0077 | -- | 0.0077 | 0.0077 | 0 |
| FQ3 2026 (Sep 2026) | 0.0168 | -- | 0.0168 | 0.0168 | 0 |
| FQ2 2026 (Jun 2026) | 0.0255 | -34.12 | 0.0255 | 0.0255 | 0 |
| FQ1 2026 (Mar 2026) | 0.01 | -- | 0.01 | 0.01 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 1 |
| FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 1 |
| FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 1 |
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 1 |
| FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 1 |
| FQ2 2026 (Jun 2026) | 0B | 69.58 | 0B | 0B | 1 |
| FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
1
Revenue # of Misses
4
Revenue # of in-lines
3
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2021 (Jun 2021) | -0.3089 | -0.3089 | 100% | |
| FQ2 2025 (Jun 2025) | -0.08 | 0.0342 | 0.1142 | 333.92% |
| FQ3 2024 (Sep 2024) | -0.07 | -0.23 | -0.16 | 69.57% |
| FQ4 2024 (Dec 2024) | -0.07 | -0.23 | -0.16 | 69.57% |
| FQ2 2024 (Jun 2024) | -0.07 | -0.0862 | -0.0162 | 18.79% |
| FQ3 2021 (Sep 2021) | -0.0011 | -0.0011 | 100% | |
| FQ4 2021 (Dec 2021) | -0.0111 | -0.0111 | 100% | |
| FQ1 2024 (Mar 2024) | -0.05 | -0.05 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2021 (Jun 2021) | $0B | $0B | $0M | NAN% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $-0.1M | -30.37% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $-0.29M | -634.99% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $-0.31M | -671.74% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $-0.31M | -3750.02% |
| FQ3 2021 (Sep 2021) | $0B | $0B | $0M | NAN% |
| FQ4 2021 (Dec 2021) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0.04M | 100% |